Tyra Biosciences Plans to Develop Potential Treatment of Dwarfism, File Application in H2
Tyra Biosciences Plans to Develop Potential Treatment of Dwarfism, File Application in H2
Tyra生物科技計劃開發潛在的矮小症治療方案,在下半年提交申請。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊